CD-36 variants and circulating miRNAs as prognostic biomarkers and potential therapeutic targets in breast cancer patients
Article in Gene Reports (June 2024)
The most recent citing publications are shown below. View all 824 publications that cite this research output on Dimensions.
Extracellular Vesicles and Artificial Intelligence: Unique Weapons against Breast Cancer
Article in Applied Sciences (February 2024)
MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways
Article in Cell Communication and Signaling (February 2024)